These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 3008481

  • 1. Late-onset 3 beta-ol-hydroxysteroid-dehydrogenase deficiency: prevalence, clinical presentation and endocrine pattern.
    Carmina E, Rosato F, Caputo A, Janní A.
    Acta Eur Fertil; 1985; 16(6):427-30. PubMed ID: 3008481
    [Abstract] [Full Text] [Related]

  • 2. [3 beta-hydroxysteroid dehydrogenase defect: frequency of presentation in a sample of Chilean hirsute women].
    Sapunar J, Rodriguez JA, Arteaga E, López JM, Cattani A, González G, Campino C, Rojas A, Alvarez S.
    Rev Med Chil; 1993 Jan; 121(1):11-5. PubMed ID: 8235158
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
    Morán C, Tena G, Herrera J, Bermúdez JA, Zárate A.
    Arch Med Res; 1994 Jan; 25(3):315-20. PubMed ID: 7803981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
    Medina M, Herrera J, Flores M, Martin O, Bermúdez JA, Zárate A.
    Fertil Steril; 1986 Dec; 46(6):1021-5. PubMed ID: 3023147
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.
    Lobo RA, Goebelsmann U.
    J Clin Endocrinol Metab; 1981 Aug; 53(2):394-400. PubMed ID: 6265489
    [Abstract] [Full Text] [Related]

  • 9. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY, Lerner AJ, Stoner E, Levine LS, Oberfield SE, Engel I, New MI.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of DHEAS in gynecologic endocrinopathy and infertility.
    Lobo RA, Paul WL, Goebelsmann U.
    Obstet Gynecol; 1981 May; 57(5):607-12. PubMed ID: 6261197
    [Abstract] [Full Text] [Related]

  • 11. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT, Zhang L, Alkaddour HS, Mason JI, Lin K, Yang X, Garibaldi LR, Bourdony CJ, Dolan LM, Donaldson DL.
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ.
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [Abstract] [Full Text] [Related]

  • 14. Importance of serum androgens chromatography on the acth stimulated adrenal steroidogenesis evaluation in hirsute women.
    Tafaro E, Natale R, Cignarelli M, Vitale F, Giorgino R.
    Boll Soc Ital Biol Sper; 1983 Dec 30; 59(12):1877-82. PubMed ID: 6322821
    [Abstract] [Full Text] [Related]

  • 15. Late onset adrenal hyperplasia due to 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency in north Indian hirsute women.
    Sundararaman PG, Ammini AC, Khurana ML, Karmarkar MG, Ahuja MM.
    Indian J Med Res; 1997 Jan 30; 105():27-31. PubMed ID: 9029832
    [Abstract] [Full Text] [Related]

  • 16. The relation between obesity and testosterone-estradiol binding globulin levels in polycystic ovarian syndrome (PCO).
    Badawy SZ, Weigert JM, Marshall LD, Cuenca VG.
    Diagn Gynecol Obstet; 1980 Jan 30; 2(1):43-6. PubMed ID: 7193560
    [Abstract] [Full Text] [Related]

  • 17. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 30; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A, Dittrich R, Cupisti S, Beckmann MW, Binder H.
    Exp Clin Endocrinol Diabetes; 2006 Apr 30; 114(4):182-7. PubMed ID: 16705550
    [Abstract] [Full Text] [Related]

  • 20. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.
    Gynecol Endocrinol; 2005 Sep 30; 21(3):154-60. PubMed ID: 16335907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.